Kezar Life Sciences, Inc. — Investor Relations & Filings
Filings indexed
442
across all filing types
Latest filing
2026-05-11
Delisting Announcement
Country
US
United States of America
Listing
US
KZR
Kezar Life Sciences is a clinical-stage biotechnology company focused on the discovery and development of novel, first-in-class small molecule therapeutics. The company advances unique protein-targeting approaches designed to inhibit multiple disease-driving cellular pathways and address the limitations of available treatments. Its development pipeline focuses on creating breakthrough therapies for immune-mediated diseases, liver disease, and oncologic disorders.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 25-NSE - Kezar Life Sciences, Inc. (0001645666) (Subject) | 2026-05-11 | English | |
| 8-K - Kezar Life Sciences, Inc. (0001645666) (Filer) | 2026-05-11 | English | |
| 10-Q - Kezar Life Sciences, Inc. (0001645666) (Filer) | 2026-05-11 | English | |
| 10-K/A - Kezar Life Sciences, Inc. (0001645666) (Filer) | 2026-04-30 | English | |
| 8-K - Kezar Life Sciences, Inc. (0001645666) (Filer) | 2026-04-03 | English | |
| SC14D9C - Kezar Life Sciences, Inc. (0001645666) (Subject) | 2026-03-30 | English |
Browse filings by year
11 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
8 filings
| |||||
| 44971026 | 25-NSE - Kezar Life Sciences, Inc. (0001645666) (Subject) | 2026-05-11 | English | ||
| 44963991 | 8-K - Kezar Life Sciences, Inc. (0001645666) (Filer) | 2026-05-11 | English | ||
| 44934381 | 10-Q - Kezar Life Sciences, Inc. (0001645666) (Filer) | 2026-05-11 | English | ||
| 39212850 | 10-K/A - Kezar Life Sciences, Inc. (0001645666) (Filer) | 2026-04-30 | English | ||
| 33303704 | 8-K - Kezar Life Sciences, Inc. (0001645666) (Filer) | 2026-04-03 | English | ||
| 33088230 | SC14D9C - Kezar Life Sciences, Inc. (0001645666) (Subject) | 2026-03-30 | English | ||
| 33088223 | 8-K - Kezar Life Sciences, Inc. (0001645666) (Filer) | 2026-03-30 | English | ||
| 31089418 | SCHEDULE 13G/A Filing | 2026-02-09 | English | ||
|
2025
7 filings
| |||||
| 12883951 | Major Shareholding Notification 2025 | 2025-11-14 | English | ||
| 12883952 | 10-Q | 2025-11-12 | English | ||
| 12883953 | 8-K | 2025-11-12 | English | ||
| 12883954 | 8-K | 2025-11-07 | English | ||
| 12883955 | 8-K | 2025-10-22 | English | ||
| 12883956 | 8-K | 2025-10-16 | English | ||
| 12883957 | Major Shareholding Notification 2025 | 2025-09-08 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
CS Medica A/S
Develops and manufactures OTC medical devices and cosmetics…
|
CSMED | DK | Manufacturing |
|
CSPC Innovation Pharmaceutical Co.,Ltd.
Global supplier of caffeine, pharmaceutical ingredients, an…
|
300765 | CN | Manufacturing |
|
CSPC Pharmaceutical Group Limited
R&D, manufacturing, and sale of innovative finished and bul…
|
1093 | HK | Manufacturing |
|
CStone Pharmaceuticals
Innovation-driven biopharma focused on R&D and commercializ…
|
2616 | KY | Manufacturing |
|
CTC BIO, INC.
Develops and manufactures human and animal health products …
|
060590 | KR | Manufacturing |
|
Cue Biopharma, Inc.
Develops biologics to selectively modulate the immune syste…
|
CUE | US | Manufacturing |
|
Cullinan Therapeutics, Inc.
A clinical-stage biopharmaceutical company developing thera…
|
CGEM | US | Manufacturing |
|
CUMBERLAND PHARMACEUTICALS INC
Acquires, develops, and commercializes branded drugs for ho…
|
CPIX | US | Manufacturing |
|
Cuorips Inc.
Develops iPS cell-derived therapies and provides cell proce…
|
4894 | JP | Manufacturing |
|
Cuprina Holdings (Cayman) LTD
Biomedical firm developing wound care biotherapy and cosmec…
|
CUPR | US | Manufacturing |
Kezar Life Sciences, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34845/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34845 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34845 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34845 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34845}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Kezar Life Sciences, Inc. (id: 34845)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.